Susan P Weinstein, Priscilla J Slanetz, Alana A Lewin, Tracy Battaglia, Anees B Chagpar, Sandra Dayaratna, Elizabeth H Dibble, Mita Sanghavi Goel, Jessica H Hayward, Charlotte D Kubicky, Huong T Le-Petross, Mary S Newell, Matthew F Sanford, John R Scheel, Nina S Vincoff, Katherine Yao, Linda Moy
Mammography remains the only validated screening tool for breast cancer, however, there are limitations to mammography. One of the limitations of mammography is the variable sensitivity based on breast density. Supplemental screening may be considered based on the patient's risk level and breast density. For average-risk women with nondense breasts, the sensitivity of digital breast tomosynthesis (DBT) screening is high; additional supplemental screening is not warranted in this population. For average-risk women with dense breasts, given the decreased sensitivity of mammography/DBT, this population may benefit from additional supplemental screening with contrast-enhanced mammography, screening ultrasound (US), breast MRI, or abbreviated breast MRI...
November 2021: Journal of the American College of Radiology: JACR